DETRIMENTAL IMPACT OF TOXICITY ON QUALITY OF LIFE IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH LENVATINIBOR SORAFENIB

被引：1
|
作者：
Hudgens, S. [1 ]
Misurski, D. [2 ]
Meier, G. [2 ]
机构：
[1] Clin Outcomes Solut, Tucson, AZ USA
[2] Eisai Inc, Woodcliff Lake, NJ USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.084
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN2
引用
收藏
页码：A411 / A412
页数：2
相关论文
共 50 条
  • [41] Changes of Cytokines in Cirrhosis Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
    Nagai, Hidenari
    Mukozu, Takanori
    Matui, Daigo
    Ogino, Yu
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S979 - S979
  • [42] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
  • [43] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [44] Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
    Stras, Wojciech
    Gotlib, Joanna
    Malkowski, Piotr
    Wasiak, Dariusz
    Sliwczynski, Andrzej
    Panczyk, Mariusz
    Tronina, Olga
    Brzozowska, Melania
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [45] Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma
    Personeni, Nicola
    Rimassa, Lorenza
    Pressiani, Tiziana
    Destro, Annarita
    Ligorio, Claudia
    Tronconi, Maria Chiara
    Bozzarelli, Silvia
    Carnaghi, Carlo
    Di Tommaso, Luca
    Giordano, Laura
    Roncalli, Massimo
    Santoro, Armando
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1179 - 1187
  • [46] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [47] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
    Soria, Anna
    Calvo, Mariona
    Casas, Meritxell
    Vidales, Zara
    Munoz-Martinez, Sergio
    Sapena, Victor
    Puigvehi, Marc
    Canillas, Lidia
    Guardeno, Raquel
    Gallego, Adolfo
    Minguez, Beatriz
    Horta, Diana
    Clos, Ariadna
    Montoliu, Silvia
    Roget, Merce
    Reig, Maria
    Vergara, Mercedes
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Targeted genome profiling in patients with advanced hepatocellular carcinoma treated with sorafenib
    Kang, Wonseok
    Kim, Kyung
    Lee, Joon Hyeok
    Lim, Ho Yeong
    Park, Woong-Yang
    Lee, Jeeyun
    Paik, Yong Han
    CANCER RESEARCH, 2017, 77
  • [50] Nivolumab plus Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib
    Tsang, Josephine
    Wong, Jeffrey Sum Lung
    Kwok, Gerry Gin Wai
    Li, Bryan Cho Wing
    Leung, Roland
    Chiu, Joanne
    Cheung, Tan to
    Yau, Thomas
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (06) : 589 - 598
12345